Patients benefit from earlier access to technologies that could improve or save lives, as the MHRA approved 17 per cent more clinical investigations ...
With the introduction of adaptive deep brain stimulation (aDBS) for Parkinson's disease, new questions emerge regarding who, why, and how to treat. This paper outlines the pathophysiological rationale ...
Somewhere along the way, boredom got labeled as a problem to fix instead of a signal to listen to. The moment life goes quiet, many of us reach for a screen, a snack, a task, or even an unnecessary ...
Discover how TMS therapy targets depression at the source. A deep dive into the physics, safety protocols, and FDA-cleared ...
More than one million Americans are living with Parkinson’s disease and another 90,000 people are expected to be diagnosed ...
BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today commented on the recent news issued by Evernorth® ...
PsyPost on MSN
Ibogaine appears to trigger an accelerated “auto-psychotherapy” process during PTSD treatment
A new study published in npj Mental Health Research suggests that U.S. Special Operations veterans treated with a combination ...
The vagus nerve is the “master regulator of inflammation and stress”, and stimulating it regularly can have profound health ...
Deep brain stimulation involves sending electrical signals to a specific brain area via surgically implanted electrodes.
Over the last few years, evidence has piled up that psychedelic drugs can provide relatively rapid relief from the symptoms ...
From advanced surgical options to next-generation medications and cell-based therapies, researchers are closer than ever to changing the future of Parkinson’s.
QuantalX combined transcranial magnetic stimulation and EEG technology in its first-of-its-kind brain network function ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results